Uncover the full discovery potential of liquid biopsy
Using
a simple blood sample, free-floating nucleic acids or nucleic acids from circulating cells and exosomes can reveal valuable insights into genomic drivers of cancer development or chromosome aneuploidies in fetal development research. This genomic analysis of peripheral blood, known as a “liquid biopsy”, presents a low-cost, low-risk way to access valuable genomic information without invasive surgical procedures. QIAseq NGS products enable you to uncover the full discovery potential from any liquid biopsy sample. ...
Read more
Using
a simple blood sample, free-floating nucleic acids or nucleic acids from circulating cells and exosomes can reveal valuable insights into genomic drivers of cancer development or chromosome aneuploidies in fetal development research. This genomic analysis of peripheral blood, known as a “liquid biopsy”, presents a low-cost, low-risk way to access valuable genomic information without invasive surgical procedures. QIAseq NGS products enable you to uncover the full discovery potential from any liquid biopsy sample.QIAseq NGS products for liquid biopsy offer:
- Smooth integration with QIAGEN sample extraction technologies to maximize sample carry-over to NGS workflow
- High adapter ligation efficiencies to maximize library yields
- Even representation of the genome for in-depth genomic analysis – even from single cells
- Specific target-enrichment of cancer-related genes
- Sensitive detection of relevant mutations down to 1% allelic frequency
Hide details